Systems serology of responses against tumor antigens in ovarian cancer reveal disrupted Fc-mediated immunity
Michelle Loui, Meera Trisal, Laura B. James‐Allan, Scott D. Taylor, Het Desai, Gabriella DiBernardo, Allison Brookhart, Yun-Rong Ting, Jessica Gebraeel, Neda A. Moatamed, Pamela K. Kreeger, Sanaz Memarzadeh, Aaron S. Meyer
This study identifies tumor-binding autoantibodies in ovarian cancer patients that fail to engage Fc{gamma}RIIIa, impairing antibody-dependent cellular cytotoxicity.
bioRxiv · Apr 29, 2026 · PreprintCancer Biology